NO20011437L - Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediens - Google Patents

Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediens

Info

Publication number
NO20011437L
NO20011437L NO20011437A NO20011437A NO20011437L NO 20011437 L NO20011437 L NO 20011437L NO 20011437 A NO20011437 A NO 20011437A NO 20011437 A NO20011437 A NO 20011437A NO 20011437 L NO20011437 L NO 20011437L
Authority
NO
Norway
Prior art keywords
treat
active ingredient
eye drops
natriuretic peptide
lacrimal secretion
Prior art date
Application number
NO20011437A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011437D0 (no
Inventor
Katsuhiko Nakata
Masatsugu Nakamura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20011437D0 publication Critical patent/NO20011437D0/no
Publication of NO20011437L publication Critical patent/NO20011437L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO20011437A 1998-09-28 2001-03-21 Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediens NO20011437L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27333298 1998-09-28
PCT/JP1999/005239 WO2000018422A1 (fr) 1998-09-28 1999-09-24 Promoteurs de secretion lacrymale ou gouttes ophtalmologiques contenant des peptides natriuretiques comme principes actifs pour traiter la keratoconjonctivite

Publications (2)

Publication Number Publication Date
NO20011437D0 NO20011437D0 (no) 2001-03-21
NO20011437L true NO20011437L (no) 2001-03-21

Family

ID=17526421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011437A NO20011437L (no) 1998-09-28 2001-03-21 Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediens

Country Status (7)

Country Link
US (1) US6833358B1 (fr)
EP (1) EP1118329A4 (fr)
KR (1) KR100691545B1 (fr)
CN (1) CN1169573C (fr)
CA (1) CA2345414A1 (fr)
NO (1) NO20011437L (fr)
WO (1) WO2000018422A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
CA2647143A1 (fr) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Constructions de peptides natriuretiques cycliques
AU2007233123A1 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
CN101674807B (zh) * 2007-05-04 2013-03-20 博士伦公司 用于缓解、改善、治疗或预防干眼症的组合物及其制备和使用方法
KR20100016285A (ko) * 2007-05-07 2010-02-12 보오슈 앤드 롬 인코포레이팃드 안구건조 상태를 감소, 개선, 치료 또는 예방하기 위한 조성물 및 이의 제조 및 사용 방법
RU2572694C2 (ru) 2009-07-23 2016-01-20 ИГИСУ Ко., Лтд. Композиция кожного препарата для наружного применения
BR112012004058A2 (pt) 2009-08-27 2021-08-17 Kyoko Endo preparação terapêutica para rinite
US8551938B2 (en) * 2009-09-25 2013-10-08 Alcon Research, Ltd. NPR-B agonists
KR101854820B1 (ko) 2009-09-25 2018-05-04 샤이어 오펀 테라피즈 게엠베하 신규한 ｎｐｒ－ｂ 길항제
AR078446A1 (es) 2009-12-18 2011-11-09 Alcon Res Ltd Agonistas de npr-b. uso.
CN101947307B (zh) * 2010-08-19 2012-08-15 中山大学中山眼科中心 人胎盘肽在制备治疗干眼症等眼表疾病药物中的应用
US20120277155A1 (en) 2011-02-25 2012-11-01 Medtronic, Inc. Therapy for kidney disease and/or heart failure
EP2750697A4 (fr) 2011-09-02 2015-03-25 Medtronic Inc Compositions de peptides natriurétiques chimériques et procédés de préparation
WO2013127834A1 (fr) 2012-02-28 2013-09-06 Ge Healthcare As Flacon à soupape à flotteur libre pour produit pharmaceutique stérile
IL293979B1 (en) 2016-01-08 2024-04-01 Ascendis Pharma Growth Disorders As Controlled-release CNP agonists with increased NEP stability
MX2018008061A (es) 2016-01-08 2018-08-23 Ascendis Pharma Growth Disorders As Profarmacos de peptido natriuretico tipo c (cnp) con porciones portadoras grandes.
AU2017205693B2 (en) 2016-01-08 2022-03-31 Ascendis Pharma Growth Disorders A/S Controlled-release CNP agonists with low initial NPR-B activity
EP3400021A1 (fr) 2016-01-08 2018-11-14 Ascendis Pharma Growth Disorders A/S Agonistes de cnp à libération contrôlée présentant une faible liaison à npr-c
HRP20221339T1 (hr) 2016-01-08 2023-01-06 Ascendis Pharma Growth Disorders A/S Cnp predlijekovi s učvršćenjem nosača na cikličkom dijelu peptida
WO2017118707A1 (fr) 2016-01-08 2017-07-13 Ascendis Pharma Growth Disorders A/S Agonistes de cnp à libération contrôlée présentant des effets secondaires réduits
CA3037448A1 (fr) 2016-09-29 2018-04-05 Ascendis Pharma Growth Disorders A/S Therapie combinee d'agonistes de cnp a liberation controlee

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPS60136596A (ja) 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
DE69020755T3 (de) 1989-03-01 2000-03-02 Shionogi & Co Physiologisch aktives Polypeptid und DNA.
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
JP2930380B2 (ja) 1990-07-13 1999-08-03 壽之 松尾 ブタ由来新規生理活性ペプチド（ｃｎｐ―５３）
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
AU6360394A (en) * 1993-03-03 1994-09-26 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
WO1995033769A1 (fr) * 1994-06-02 1995-12-14 Boehringer Mannheim Gmbh Procede et produits intermediaires utiles pour preparer des fragments de cardiodilatine, et fragments tres purs de cardiodilatine
JPH10218792A (ja) * 1997-02-12 1998-08-18 Santen Pharmaceut Co Ltd アンギオテンシン変換酵素阻害薬を有効成分とする涙液分泌促進および角結膜障害治療剤
JPH10236972A (ja) 1997-02-28 1998-09-08 Mitsubishi Chem Corp 涙液分泌促進剤

Also Published As

Publication number Publication date
NO20011437D0 (no) 2001-03-21
EP1118329A4 (fr) 2004-12-15
CN1320040A (zh) 2001-10-31
CN1169573C (zh) 2004-10-06
EP1118329A1 (fr) 2001-07-25
KR100691545B1 (ko) 2007-03-09
KR20010073181A (ko) 2001-07-31
CA2345414A1 (fr) 2000-04-06
WO2000018422A1 (fr) 2000-04-06
US6833358B1 (en) 2004-12-21

Similar Documents

Publication Publication Date Title
NO20011437L (no) Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediens
CA2261760A1 (fr) Sulfonamides et derives de ceux-ci, modulant l'activite de l'endotheline
BG105643A (en) Carboxylic acids and carboxylic acid isosteres of n-heterocycle compounds
WO2002048183A3 (fr) Compositions de cristaux de peptides
CA2447924A1 (fr) Formulations d'olopatadine a administration topique
HUP0300833A3 (en) Gabapentin analogues for treating sleep disorders
NO20043663L (no) Bicykliske aminosyrer som farmasoytiske midler
ATE344027T1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
CA2260145A1 (fr) Utilisation de l-acetylcarnitine, de l-isovalerycarnitine, de l-propionylcarnitine pour augmenter les taux de igf-1
BG105012A (en) N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic isosteres
DK0725097T3 (da) Anvendelse af humant atrialt natriuretisk peptid til fremstilling af farmaceutiske præparater til behandling af akut lungeb
DK0872247T3 (da) Topisk formulering indeholdende phosphatbuffer som hudgennemtrængningsfremmer
IL150311A0 (en) Sulfonamides and derivatives thereof that modulate the activity of endothelin
DE69818026D1 (de) Wässrige suspension zur nasalen verabreichung von loteprednol
ATE497390T1 (de) Neue therapeutische verwendung von smr-1 peptide
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
WO2000009103A3 (fr) Sulfonamides a liaison n d'acides carboxyliques n-heterocycliques ou isosteres, destines a des troubles de la vision et de la memoire
HK1112738A1 (en) Arylsulfonamides and analogues as well as use for the treatment of neuro- degenerative disorders
FI883643A (fi) Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna.
DK0973505T3 (da) Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand
NO20032035L (no) Terapeutiske midler for keratokonjuktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens
DE69731620D1 (de) Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheiten
CA2409546A1 (fr) Peptides et derives presentant une activite de fixation, de propagation et d'ablation cellulaire
SE0103476D0 (sv) New use
HRP20000665B1 (en) CRYSTALLINE FORMS OF 1S-[1alpha(2S*,3R*), 9alpha]10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANYL)-9-[[(1-ISOQUINOLYL)CARBONYL]-AMINO]OCTAHYDRO-6H-PIRIDAZINO[1,2-A][1,2]DIAZEPIN- 1-CARBOXAMIDE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application